Raymond James Financial
TYRA icon

Raymond James Financial’s Tyra Biosciences TYRA Stock Holding History

Raymond James Financial’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.78M Sell
180,881
-66,217
-27% -$2.19M ﹤0.01% 2619
2026
Q1 		$9.46M Buy
247,098
+77,066
+45% +$2.49M ﹤0.01% 2073
2025
Q4 		$4.47M Buy
170,032
+43,658
+35% +$802K ﹤0.01% 2609
2025
Q3 		$1.77M Buy
126,374
+63,187
+100% +$720K ﹤0.01% 3259
2025
Q2 		$605K Buy
63,187
+8,843
+16% +$84K ﹤0.01% 3891
2025
Q1 		$505K Sell
54,344
-439
-0.8% -$5.68K ﹤0.01% 3936
2024
Q4 		$761K Buy
+54,783
New +$994K ﹤0.01% 3641

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Raymond James Financial's TYRA Position: Q2 2026 in Review

Raymond James Financial reduced its Tyra Biosciences (TYRA) stake by 27% in Q2 2026, selling an estimated $2.19M and leaving 180,881 shares worth $5.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

Raymond James Financial first reported a position in TYRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.46M in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Raymond James Financial held 180,881 shares of Tyra Biosciences worth $5.78M as of Q2 2026.
  • Raymond James Financial sold 66,217 Tyra Biosciences shares in Q2 2026, an estimated $2.19M.
  • Tyra Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2619 holding.
  • Raymond James Financial first reported a position in Tyra Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Tyra Biosciences position peaked at $9.46M in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.